Skip to main content

selcodebart

Generic: Selcodebart

selcodebart: 3 clinical trials tracked.

selcodebart evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about selcodebart, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 1 study sponsors
Clinical Trial Registry Records (3)

RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation

NCT07368972Registry updated 2026-09-23·Phase 2·IRON
Recruiting

Primary endpoint: Maximal change from baseline in Hgb through Day 85

InterventionalRandomizedquadruple21 targetStarted 2026-02Completion 2027-0315 sites · United StatesDisc Medicine, Inc

A Phase 1b Multicenter, Randomized, Double-Blind, Placebo-Controlled Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DISC-0974 in Participants With Non-Dialysis Dependent Chronic Kidney Disease and Anemia

NCT05745883Registry updated 2026-04-22·Phase 1·IRON
Completed

Primary endpoint: Incidence of treatment-emergent adverse events

InterventionalRandomizedquadruple55 enrolledStarted 2023-04Completion 2026-0113 sites · United StatesDisc Medicine, Inc

RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT05320198Registry updated 2026-09-23·Phase 1/Phase 2·IRON
Recruiting

Primary endpoint: Safety and Tolerability of DISC-0974 (Phase 1b only)

InterventionalRandomizedopen150 targetStarted 2022-06Completion 2027-0632 sites · Australia, United StatesDisc Medicine, Inc